vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and DiamondRock Hospitality Co (DRH). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $258.2M, roughly 1.1× DiamondRock Hospitality Co). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 5.6%, a 90.7% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 1.3%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -8.6%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
DiamondRock Hospitality Co is a US-based real estate investment trust owning and operating a portfolio of premium upscale hotels and resorts. Its properties are mainly located in major urban tourist and business hubs nationwide, catering to both leisure and corporate clientele seeking high-quality accommodation services.
ACAD vs DRH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $258.2M |
| Net Profit | $273.6M | $14.5M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 11.1% |
| Net Margin | 96.3% | 5.6% |
| Revenue YoY | 9.4% | 1.3% |
| Net Profit YoY | 90.3% | 22.0% |
| EPS (diluted) | $1.61 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $258.2M | ||
| Q4 25 | $284.0M | $274.5M | ||
| Q3 25 | $278.6M | $285.4M | ||
| Q2 25 | $264.6M | $305.7M | ||
| Q1 25 | $244.3M | $254.9M | ||
| Q4 24 | $259.6M | $279.1M | ||
| Q3 24 | $250.4M | $285.1M | ||
| Q2 24 | $242.0M | $309.3M |
| Q1 26 | — | $14.5M | ||
| Q4 25 | $273.6M | $26.2M | ||
| Q3 25 | $71.8M | $22.5M | ||
| Q2 25 | $26.7M | $40.8M | ||
| Q1 25 | $19.0M | $11.9M | ||
| Q4 24 | $143.7M | $-11.2M | ||
| Q3 24 | $32.8M | $26.4M | ||
| Q2 24 | $33.4M | $24.5M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | — | 11.1% | ||
| Q4 25 | 6.1% | 8.9% | ||
| Q3 25 | 12.8% | 8.1% | ||
| Q2 25 | 12.2% | 13.7% | ||
| Q1 25 | 7.9% | 4.3% | ||
| Q4 24 | 59.1% | -3.7% | ||
| Q3 24 | 12.6% | 9.5% | ||
| Q2 24 | 12.6% | 8.4% |
| Q1 26 | — | 5.6% | ||
| Q4 25 | 96.3% | 9.5% | ||
| Q3 25 | 25.8% | 7.9% | ||
| Q2 25 | 10.1% | 13.4% | ||
| Q1 25 | 7.8% | 4.7% | ||
| Q4 24 | 55.4% | -4.0% | ||
| Q3 24 | 13.1% | 9.3% | ||
| Q2 24 | 13.8% | 7.9% |
| Q1 26 | — | $0.07 | ||
| Q4 25 | $1.61 | $0.12 | ||
| Q3 25 | $0.42 | $0.10 | ||
| Q2 25 | $0.16 | $0.18 | ||
| Q1 25 | $0.11 | $0.04 | ||
| Q4 24 | $0.86 | $-0.06 | ||
| Q3 24 | $0.20 | $0.11 | ||
| Q2 24 | $0.20 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $39.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $1.4B |
| Total Assets | $1.6B | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $39.3M | ||
| Q4 25 | $177.7M | $68.1M | ||
| Q3 25 | $258.0M | $145.3M | ||
| Q2 25 | $253.6M | $52.4M | ||
| Q1 25 | $217.7M | $100.6M | ||
| Q4 24 | $319.6M | $81.4M | ||
| Q3 24 | $155.1M | $75.3M | ||
| Q2 24 | $177.1M | $125.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.2B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $917.3M | $1.6B | ||
| Q2 25 | $822.4M | $1.6B | ||
| Q1 25 | $765.2M | $1.6B | ||
| Q4 24 | $732.8M | $1.6B | ||
| Q3 24 | $577.2M | $1.6B | ||
| Q2 24 | $516.7M | $1.6B |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $1.6B | $3.0B | ||
| Q3 25 | $1.3B | $3.1B | ||
| Q2 25 | $1.2B | $3.1B | ||
| Q1 25 | $1.1B | $3.1B | ||
| Q4 24 | $1.2B | $3.2B | ||
| Q3 24 | $976.9M | $3.2B | ||
| Q2 24 | $914.1M | $3.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.65× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.69× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.71× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $67.9M | ||
| Q3 25 | $74.3M | $74.6M | ||
| Q2 25 | $64.0M | $73.6M | ||
| Q1 25 | $20.3M | $27.6M | ||
| Q4 24 | $40.4M | $75.8M | ||
| Q3 24 | $63.2M | $61.7M | ||
| Q2 24 | $25.0M | $55.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $47.3M | ||
| Q3 25 | $73.9M | $54.9M | ||
| Q2 25 | — | $57.9M | ||
| Q1 25 | — | $2.0M | ||
| Q4 24 | — | $52.6M | ||
| Q3 24 | $63.2M | $39.0M | ||
| Q2 24 | — | $38.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 17.2% | ||
| Q3 25 | 26.5% | 19.2% | ||
| Q2 25 | — | 18.9% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 18.9% | ||
| Q3 24 | 25.2% | 13.7% | ||
| Q2 24 | — | 12.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 7.5% | ||
| Q3 25 | 0.1% | 6.9% | ||
| Q2 25 | — | 5.1% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | 8.3% | ||
| Q3 24 | 0.0% | 7.9% | ||
| Q2 24 | — | 5.5% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 2.59× | ||
| Q3 25 | 1.03× | 3.31× | ||
| Q2 25 | 2.40× | 1.80× | ||
| Q1 25 | 1.07× | 2.33× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 2.33× | ||
| Q2 24 | 0.75× | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
DRH
| Rooms | $164.1M | 64% |
| Food and beverage | $67.2M | 26% |
| Other | $26.9M | 10% |
